Thus, future research should focus on precise and large-scale clinical studies with well-designed protocols, as well as comprehensive animal experiments, to better understand the regulatory role of BMP9 in NAFLD. Here, GDF2 is linked to metabolic dysfunction-associated steatotic liver disease.